forecast

Platform Technology Faces Competitive Substitution Risk

Moderna's main risks include drugs failing for unknown biological reasons and next-generation competitors, since alternative technologies may replace missing-protein therapy at scale and other mRNA companies could leapfrog Moderna.

forecastpending

Speaker

Matthew Harrison

Evidence Quote

“There are three or four or five other technologies that can potentially do that and potentially do it at scale.”

Source

Moderna: The Software of Life— Business Breakdowns
Created: 11/15/2026, 7:57:10 PM

Your notes

Loading notes...